{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:24:54Z","timestamp":1785943494824,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.rbmo.2022.10.012","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T07:10:50Z","timestamp":1667286650000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prediction of ovarian response using the automated Elecsys anti-M\u00fcllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles"],"prefix":"10.1016","volume":"46","author":[{"given":"Ernesto","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Labarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Zuzuarregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatina","family":"Iliodromiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2022.10.012_bib0001","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2019.02.022","article-title":"Evaluation of the Elecsys anti-mullerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol","volume":"236","author":"Anckaert","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.01.004","article-title":"Prospective study into the value of the automated Elecsys antim\u00fcllerian hormone assay for the assessment of the ovarian growing follicle pool","volume":"103","author":"Anderson","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0003","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0004","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.fertnstert.2021.01.056","article-title":"Validation study of the Access antim\u00fcllerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation","volume":"116","author":"Baker","year":"2021","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.03.031","article-title":"Multicenter evaluation of the Access AMH antim\u00fcllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation","volume":"110","author":"Baker","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0006","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1515\/cclm-2021-0698","article-title":"Intra- and inter-cycle variability of anti-M\u00fcllerian hormone (AMH) levels in healthy women during non-consecutive menstrual cycles: the BICYCLE study","volume":"60","author":"Biniasch","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0007","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Human Reprod. Update"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0008","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Human Reprod. Update"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0010","first-page":"26","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Human Reprod","volume":"19","author":"Broer","year":"2013","journal-title":"Update"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0011","unstructured":"Clayton, P. (2013). CUTPT: Stata module for empirical estimation of cutpoint for a diagnostic test. Retrieved fromhttps:\/\/EconPapers.repec.org\/RePEc:boc:bocode:s457719"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0012","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00325","article-title":"Anti-m\u00fcllerian Hormone for the prediction of ovarian response in progestin-primed ovarian stimulation protocol for IVF","volume":"10","author":"Huang","year":"2019","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0014","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.rbmo.2018.12.041","article-title":"A multicentre evaluation of the Elecsys\u00ae anti-M\u00fcllerian hormone immunoassay for prediction of antral follicle count","volume":"38","author":"Jacobs","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0015","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/humrep\/deu142","article-title":"Biological variability in serum anti-M\u00fcllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women","volume":"29","author":"Kissell","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0016","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0017","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0015-0282(16)57916-3","article-title":"Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization","volume":"64","author":"Licciardi","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0018","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)60077-8","article-title":"The value of basal and\/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome","volume":"50","author":"Muasher","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0019","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/cen.13956","article-title":"Anti-m\u00fcllerian hormone variability and its implications for the number of oocytes retrieved following individualized dosing with follitropin delta","volume":"90","author":"Nelson","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antim\u00fcllerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0021","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI\u2020","volume":"2020","author":"Ovarian Stimulation TEGGO","year":"2020","journal-title":"Human Reprod. Open"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0023","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","year":"2020","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.719029","article-title":"Variation in the measurement of anti-m\u00fcllerian hormone - what are the laboratory issues?","volume":"12","author":"Punchoo","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.rbmo.2022.10.012_bib0025","unstructured":"Roche Diagnostics GmbH. Elecsys AMH method sheet v6.0. 2021-07."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0015-0282(97)81865-1","article-title":"Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome","volume":"67","author":"Seifer","year":"1997","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0027","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0015-0282(16)57974-6","article-title":"Prognostic value of day 3 estradiol on in vitro fertilization outcome","volume":"64","author":"Smotrich","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2022.10.012_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.046","article-title":"Comparability of antim\u00fcllerian hormone levels among commercially available immunoassays","volume":"101","author":"Su","year":"2014","journal-title":"Fertil. Steril."}],"updated-by":[{"DOI":"10.1016\/j.rbmo.2024.103946","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648322007672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648322007672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T22:53:45Z","timestamp":1716936825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648322007672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1472648322007672"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2022.10.012","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.rbmo.2024.103946","asserted-by":"object"}]},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of ovarian response using the automated Elecsys anti-M\u00fcllerian hormone assay in gonadotrophin-releasing hormone antagonist cycles","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2022.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}]}}